Modern therapeutic approaches for the treatment of malignant liver tumours
H Petrowsky, R Fritsch, M Guckenberger… - Nature reviews …, 2020 - nature.com
Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …
Stereotactic body radiotherapy for colorectal cancer liver metastases: a systematic review
F Petrelli, T Comito, S Barni, G Pancera… - Radiotherapy and …, 2018 - Elsevier
Introduction While surgery is the preferred option for isolated, operable liver metastases from
colorectal cancer (CRC), ablative techniques are endorsed for medically or technically …
colorectal cancer (CRC), ablative techniques are endorsed for medically or technically …
[HTML][HTML] S3-leitlinie–kolorektales karzinom
W Schmiegel, B Buchberger… - Zeitschrift für …, 2017 - thieme-connect.com
2.1 Geltungsbereich und Zweck 2.1. 1. Zielsetzung und Fragestellung Das Kolorektale
Karzinom (KRK) ist mit etwa 64 000 Neuerkrankungen und ca. 26 000 Todesfällen pro Jahr …
Karzinom (KRK) ist mit etwa 64 000 Neuerkrankungen und ca. 26 000 Todesfällen pro Jahr …
[HTML][HTML] ESTRO-ACROP guideline: Recommendations on implementation of breath-hold techniques in radiotherapy
The use of breath-hold techniques in radiotherapy, such as deep-inspiration breath hold, is
increasing although guidelines for clinical implementation are lacking. In these …
increasing although guidelines for clinical implementation are lacking. In these …
Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer
M Scorsetti, T Comito, A Tozzi, P Navarria… - Journal of cancer …, 2015 - Springer
Purpose To evaluate the feasibility and efficacy of stereotactic body radiation therapy
(SBRT) in the treatment of colorectal liver metastases. Methods Forty-two patients with …
(SBRT) in the treatment of colorectal liver metastases. Methods Forty-two patients with …
[HTML][HTML] Microwave ablation, radiofrequency ablation, irreversible electroporation, and stereotactic ablative body radiotherapy for intermediate size (3–5 cm) …
S Nieuwenhuizen, M Dijkstra, RS Puijk… - Current Oncology …, 2022 - Springer
Abstract Purpose of Review Based on good local control rates and an excellent safety
profile, guidelines consider thermal ablation the gold standard to eliminate small …
profile, guidelines consider thermal ablation the gold standard to eliminate small …
Radiotherapy for liver metastases: a review of evidence
Over the past decade, there has been an increasing use of radiotherapy (RT) for the
treatment of liver metastases. Most often, ablative doses are delivered to focal liver …
treatment of liver metastases. Most often, ablative doses are delivered to focal liver …
Novel insights of oligometastases and oligo‐recurrence and review of the literature
Y Niibe, JY Chang - Pulmonary medicine, 2012 - Wiley Online Library
Oligometastases and oligo‐recurrence are among the most important notions of metastatic
and recurrent cancer. The concept of oligometastases is related to the notion that cancer …
and recurrent cancer. The concept of oligometastases is related to the notion that cancer …
[HTML][HTML] Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach
T Comito, L Cozzi, E Clerici, MC Campisi, RLE Liardo… - BMC cancer, 2014 - Springer
Background To assess the safety and efficacy of Stereotactic Ablative Radiotherapy (SABR)
in oligometastatic patients from colorectal cancer. Methods 82 patients with 1–3 inoperable …
in oligometastatic patients from colorectal cancer. Methods 82 patients with 1–3 inoperable …
[HTML][HTML] Stereotactic body radiation therapy for liver metastases
M Scorsetti, E Clerici, T Comito - Journal of gastrointestinal …, 2014 - ncbi.nlm.nih.gov
Over the years, early diagnosis of metastatic disease has improved and the prevalence of
oligometastatic patients is increasing. Liver is a most common site of progression from …
oligometastatic patients is increasing. Liver is a most common site of progression from …